All Biotech News

List of articles in category All Biotech News
Title	Published Date
Fresenius Kabi, TQ Therapeutics Announce Cell Therapy Technology Agreement	01/14/2026
BioMed X Launches XBridge Pilot to Facilitate Industry-Academic Research Collaborations	01/13/2026
Immuthera Announces Global Exclusive License from City of Hope for First-in-Class CD6/CTLA-4 CAR-Treg Platform for Autoimmune and Inflammatory Diseases	01/12/2026
Advanced Therapies Week 2026: Phacilitate Unites CGT Community for New Era Defined by Innovation and Collaboration	01/06/2026
ProBioGen and Zag Bio™ Forge Strategic CMC Partnership to Advance Fc-Fusion Autoimmune Therapy	01/06/2026
Biotium Launches GlycoLiner™ Cell Surface Glycoprotein Labeling Kits for Rapid and Selective Cell Surface Imaging	01/02/2026
T-CURX Announces $20M Series A First Closing Led by BiomedVC to Fund Pipeline of Clinical-Stage CAR-T Programs and Advance Proprietary Non-Viral In Vivo CAR-T Platform	12/17/2025
The Rada Zocco’s Foundation is Supporting The POLG Foundation	12/16/2025
FDA Clears NUZ-001 for Entry into HEALEY ALS Platform Trial	12/11/2025
ProteoNic 2G UNic® Technology Licensed by Ginkgo Bioworks for BARDA-Supported Consortium Advancing Monoclonal Antibody Manufacturing for Anti-Filovirus Therapies	12/11/2025
Perceptive eClinical Recognized as #1 Market Impact, and Overall, Leader in Everest Group’s PEAK Matrix® Assessment for RTSM Solutions 2025	12/10/2025
ProBioGen and Spica Therapeutics Announce Collaboration on GlymaxX-Enhanced CLD for Spica’s Clinical Development Candidate ST101	12/09/2025
Ryvu Therapeutics Presents New Clinical Data from RIVER-81 and POTAMI-61 Studies of Romaciclib (RVU120) at the 2025 American Society of Hematology (ASH) Annual Meeting	12/07/2025
Leadership Transition at Vetter: Thomas Otto Retires	12/03/2025
Xlife Sciences AG Delivers Breakthrough in Early Alzheimer’s Detection, Unlocking Major Market Opportunity	12/01/2025
Elanco Executive Appointed as Board Observer	11/26/2025
BioMed X Announces New Neuroscience Research Collaboration in the USA	11/25/2025
Ryvu Therapeutics Reports Third Quarter 2025 Financial Results	11/20/2025
EU-Funded TRANSCAN-3 Project Marks Key Milestones in Personalized Immunotherapy for Esophageal Cancer	11/19/2025
Biotium Expands Tyramide Signal Amplification Portfolio with Brighter and More Stable Dyes for Enhanced Spatial Imaging	11/14/2025
EpiCypher Launches Fiber-seq Kit to Democratize Single-Molecule Chromatin Mapping	11/11/2025
EpiCypher Launches CUTANA® Cloud, a Powerful Epigenomic Data Analysis Platform	11/10/2025
Touchlight Expands mbDNA™ Portfolio with New Circular DNA Architectures for Advanced Therapies	11/05/2025
Gorrissen Federspiel Is Taking its Life Sciences Advisory Services to A New Level by Hiring of a Significant Profile	11/04/2025
ABER Instruments and Sartorius Stedim Biotech Unveil BioPAT® Viamass Single-Use Biomass Sensors for Ambr® 250 High Throughput Bioreactors	11/04/2025
Ryvu Therapeutics Announces Three Abstracts on Romaciclib (RVU120) and One Abstract on Dapolsertib (MEN1703) at the 2025 American Society of Hematology (ASH) Annual Meeting	11/03/2025
EMA Grants PRIME Designation to MimeTech S.r.l. for Investigational Drug Udonitrectag Lysine in the Treatment of Diabetic Foot Ulcers (DFU)	10/29/2025
Ryvu Therapeutics Presents RVU305 (PRMT5i) and ONCO Prime Platform Data at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics	10/27/2025
Single Use Support Triples Cleanroom Capacity for Enhanced Fluid Management Solutions	10/27/2025
BD to Showcase Advanced Drug Delivery and Traceability Innovations at CPhI 2025	10/27/2025

Page 4 of 88